Do you have the same question? Follow this Question
Feb 02, 2026 - 01:09 PM
We’ve provided several answers to questions related to Invega ER (Paliperidone) , see some other helpful Q&A related to this product.
Question: What is the KEGG identifier for this medication?
Answer: The KEGG ID is D05339. KEGG (Kyoto Encyclopedia of Genes and Genomes) is a resource for understanding high-level functions of biological systems, which can be valuable for scientific research.
Question: Is this medication approved by the EU EMA?
Answer: Yes, it is approved by the European Medicines Agency (EMA). EMA approval ensures the medication is regulated and available in European countries according to stringent safety and efficacy guidelines.
Question: What is the elimination half-life of this medication?
Answer: The elimination half-life is 23 hours. The half-life represents the time it takes for half the medication to be removed from the body, which helps determine how often the medication should be taken for consistent effectiveness.
Question: Is there a 3 mg tablet available for this medication?
Answer: Yes, a 3 mg extended-release tablet is available. This strength can be used for starting doses or for patients who require a moderate dose for maintenance treatment.
Question: What is the formula of this medication?
Answer: The formula is C23H27FN4O3. This chemical formula identifies the precise molecular structure of paliperidone, which can be important for healthcare professionals and patients who want to understand the medication’s composition.
